연구성과로 돌아가기

2023 연구자 정보 (68 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Thanawala, Vaidehi
(Thanawala, V)
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med,Sch Med, Daegu, South Korea

[JCR상위 1.7] Safety and efficacy of VIR-2218 with or without pegylated interferon alfa in virally-suppressed participants with chronic hepatitis B virus infection: post-treatment follow-up SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Tougeron, David
(Tougeron, D)
ABF-3217-2020
tougeron, david

[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) SCIE 1.7 ONCOLOGY
Tsrancheva, Radoslava
(Tsrancheva, R)
Alexandrovska Univ Hosp, Sofia, Bulgaria HNC-5384-2023
Tsrancheva, Radoslava

[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY robert.c.elston@gsk.com;
Ueno, Naoto T.
(Ueno, NT)


[JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 SCIE 1.7 ONCOLOGY
Velichko, Yury
(Velichko, Y)
D-8596-2011
Velichko, Yuri

[JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) SCIE 1.7 ONCOLOGY
Vidal, Maria Jesus
(Vidal, MJ)


[JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 SCIE 1.7 ONCOLOGY
Villoro, Ruben Bueno
(Villoro, RB)
Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany
0000-0001-6398-8229
Bueno Villoro, Ruben
[JCR상위 1.7] Enhanced thermoelectric properties of NbCoSn half-Heuslers through in-situ nanocrystallization of amorphous precursors during the consolidation process SCIE 1.7 MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING yish@knu.ac.kr;p.choi@kaist.ac.kr;
Wahlstrom, Justin T.
(Wahlstrom, JT)


[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study SCIE 1.7 ONCOLOGY dmiklos@stanford.edu;
Waller, Edmund K.
(Waller, EK)
AAP-3055-2020
Waller, Edmund
0000-0003-0816-6729
Waller, Edmund K.
[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study SCIE 1.7 ONCOLOGY dmiklos@stanford.edu;
Wang, Pingan
(Wang, PA)
Kangwon Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Smart Agr, Chunchon, South Korea AAI-7159-2020
Wang, Ping-An

[JCR상위 1.7] Airborne hyperspectral imaging for early diagnosis of kimchi cabbage downy mildew using 3D-ResNet and leaf segmentation SCIE 1.7 AGRICULTURE, MULTIDISCIPLINARY;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS hanxiongzhe@kangwon.ac.kr;
Weltman, Martin
(Weltman, M)
Nepean Hosp, Penrith, Australia

[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Woo, Dongwon
(Woo, D)
제1저자 Kyungpook Natl Univ Hosp, Biomed Res Inst, Res Ctr AI Med, Sch Med, Daegu 41940, South Korea

[JCR상위 1.7] Soybean root image dataset and its deep learning application for nodule segmentation SCIE 1.7 AGRICULTURE, MULTIDISCIPLINARY;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS jeongsm00@gmail.com;kyh1229@knu.ac.kr;
Xie, Qing
(Xie, Q)
Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China

[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY robert.c.elston@gsk.com;
Yakoub-Agha, Ibrahim
(Yakoub-Agha, I)
Univ Lille, CHU Lille, INSERM U1286, Infinite, Lille, France R-7872-2018
Yakoub-Agha, Ibrahim
0000-0003-4524-8782
Yakoub-Agha, Ibrahim
[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study SCIE 1.7 ONCOLOGY dmiklos@stanford.edu;
Yamada, Takanobu
(Yamada, T)


[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer SCIE 1.7 ONCOLOGY
페이지 이동: